Blood levels of atrial natriuretic peptide, endothelin, cortisol and ACTH in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass

Journal of Endocrinological Investigation

Volumn 24, Issue 10, 2001, Pages 777-785

  Roth Isigkeit, A ^a   Dibbelt, L ^a   Eichler, W ^a   Schumacher, J ^a   Schmucker, P ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ACTH; Atrial natriuretic peptide; Cardiac surgery; Cardiopulmonary bypass; Cortisol; Endothelin; Hemodilution; HPA axis

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN; ENDOTHELIN; ENDOTHELIN 1; HYDROCORTISONE;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORTICOTROPIN BLOOD LEVEL; CRITICAL ILLNESS; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOASSAY; INTRAOPERATIVE PERIOD; MAJOR SURGERY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL;

EID: 0035202633     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343927     Document Type: Article

References (53)

1. Biphasic changes in hypothalamo-pituitary-adrenal function during the early recovery period after major abdominal surgery
2. Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery
3. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone
4. Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis
5. The role of endothelin in the control of adrenocortical function: Stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells
6. Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotropin-releasing hormone and pituitary ACTH release in vitro
7. Effects of endothelin-1 on the rat pituitary-adrenocortical axis under basal and stressful conditions
8. Effect of endothelin-1 in man - Impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin
9. Endothelin stimulates steroid secretion by frog adrenal gland in vitro: Evidence for the involvement of prostaglandins and extracellular calcium in the mechanism of action of endothelin
10. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs
11. The effects of atrial natriuretic peptide infusion on hemodynamic, renal, and hormonal responses during gastrectomy
12. Diverse biological actions of atrial natriuretic peptide
13. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor
14. Physiology of natriuretic peptides
15. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
16. Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat
17. Guanosine 3′:5′cyclic monophosphate and activators of guanylate cyclase inhibit secretagogue-induced corticotropin release by rat anterior pituitary cells
18. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man
19. Atrial natriuretic peptide is a physiological inhibitor of ACTH release: Evidence from immunoneutralization in vivo
20. Atriopeptin: An endogenous corticotropin-release inhibiting hormone
21. Pathophysiological response of cytokines and vasoactive agents in patients undergoing total gastrectomy
22. Effect of acute lung injury and coexisting disorders on plasma concentrations of atrial natriuretic peptide
23. Changes in regulators of the circulation in patients undergoing lung surgery
24. Blood levels of corticosteroid-binding globulin, total cortisol and unbound cortisol in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass
25. The effect of hemodilution on plasma levels of cortisol and free cortisol
26. Persistent endocrine stress response in patients undergoing cardiac surgery
27. The immune-endocrine interaction varies with the duration of the inflammatory process in cardiac surgery patients
28. Endothelin participates in increased circulating atrial natriuretic peptide early after human heart transplantation
29. Changes in the circulating endothelin and atrial natriuretic peptide levels during coronary artery bypass surgery
30. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-α), IL-1β, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution
31. Is the heart a source for elevated circulating endothelin levels during aorta-coronary artery bypass grafting surgery in human beings?
32. Endothelin during cardiovascular surgery: The effect of diltiazem and nitroglycerin
33. Circulating endothelin in patients undergoing coronary artery bypass grafting
34. Coronary sinus endothelin-1 concentrations after cardioplegic cardiac arrest
35. Plasma endothelin-1 levels during transient acute myocardial ischaemia in men: Effects of coronary revascularization
36. Modification of the responses of endothelin-1 to exhaustive physical exercise under stimulated high-altitude conditions with acute hypoxia
37. Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells
38. Increased plasma endothelin immunoreactivity during cardiopulmonary bypass: A preliminary observation
39. Endothelin acts as a paracrine regulator of stretch-induced atrial natriuretic peptide release
40. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction
41. Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction
42. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction
43. Plasma levels of atrial natriuretic peptide at peak exercise: A prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure
44. Renal function, neurohormonal activation, and survival in patients with chronic heart failure
45. Atrial natriuretic peptide and C-type natriuretic peptide do not acutely inhibit the release of adrenocorticotropin from equine pituitary cells in vitro
46. Atrial natriuretic peptide, cyclic GMP analogues and modulation of guanylyl cyclase do not alter stimulated POMC peptide release from perifused rat or sheep corticotrophs
47. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease
48. Circadian changes in the sensitivity of the corticotropin-releasing hormone-stimulated HPA system after arginine vasopressin and atrial natriuretic hormone in human male controls
49. Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis
50. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy man
51. Endothelin-1 stimulates the in vitro release of neurohypophyseal hormones, but not corticotropin-releasing hormone, via ETA receptors
52. Adrenal blood flow and adrenocortical response to corticotropin
53. Comparison of canine corticosteroid responses to mean and phasic increases in ACTH